APA

Arantes L. M. R. B., Laus A. C., Melendez M. E., de Carvalho A. C., Sorroche B. P., De Marchi P. R. M., Evangelista A. F., Scapulatempo-Neto C., de Souza Viana L. & Carvalho A. L. (20180220). MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. : Oncotarget.

Chicago

Arantes Lidia Maria Rebolho Batista, Laus Ana Carolina, Melendez Matias Eliseo, de Carvalho Ana Carolina, Sorroche Bruna Pereira, De Marchi Pedro Rafael Martins, Evangelista Adriane Feijó, Scapulatempo-Neto Cristovam, de Souza Viana Luciano and Carvalho André Lopes. 20180220. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. : Oncotarget.

Harvard

Arantes L. M. R. B., Laus A. C., Melendez M. E., de Carvalho A. C., Sorroche B. P., De Marchi P. R. M., Evangelista A. F., Scapulatempo-Neto C., de Souza Viana L. and Carvalho A. L. (20180220). MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. : Oncotarget.

MLA

Arantes Lidia Maria Rebolho Batista, Laus Ana Carolina, Melendez Matias Eliseo, de Carvalho Ana Carolina, Sorroche Bruna Pereira, De Marchi Pedro Rafael Martins, Evangelista Adriane Feijó, Scapulatempo-Neto Cristovam, de Souza Viana Luciano and Carvalho André Lopes. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. : Oncotarget. 20180220.